OBJECTIVE: To study the feasibility of noninvasive blood glucose monitoring using optical coherence tomography (OCT) technique in healthy volunteers. RESEARCH DESIGN AND METHODS: An OCT system with the wavelength of 1,300 nm was used in 15 healthy subjects in 18 clinical experiments. Standard oral glucose tolerance tests were performed to induce changes in blood glucose concentration. Blood samples were taken from the right arm vein every 5 or 15 min. OCT images were taken every 10-20 s from the left forearm over a total period of 3 h. The slope of the signals was calculated at the depth of 200-600 micro m from the skin surface. RESULTS: A total of 426 blood samples and 8,437 OCT images and signals were collected and analyzed in these experiments. There was a good correlation between changes in the slope of noninvasively measured OCT signals and blood glucose concentrations throughout the duration of the experiments. The slope of OCT signals changed significantly (up to 2.8% per 10 mg/dl) with variation of plasma glucose values. The good correlation obtained between the OCT signal slope and blood glucose concentration is due to the coherent detection of backscattered photons, which allows measurements of OCT signal from a specific tissue layer without unwanted signal from other tissue layers. CONCLUSIONS: This pilot study demonstrated the capability of the OCT technique to monitor blood glucose concentration noninvasively in human subjects. Further studies with a larger number of subjects including diabetic subjects are planned to validate these preliminary results.
OBJECTIVE: To study the feasibility of noninvasive blood glucose monitoring using optical coherence tomography (OCT) technique in healthy volunteers. RESEARCH DESIGN AND METHODS: An OCT system with the wavelength of 1,300 nm was used in 15 healthy subjects in 18 clinical experiments. Standard oral glucose tolerance tests were performed to induce changes in blood glucose concentration. Blood samples were taken from the right arm vein every 5 or 15 min. OCT images were taken every 10-20 s from the left forearm over a total period of 3 h. The slope of the signals was calculated at the depth of 200-600 micro m from the skin surface. RESULTS: A total of 426 blood samples and 8,437 OCT images and signals were collected and analyzed in these experiments. There was a good correlation between changes in the slope of noninvasively measured OCT signals and blood glucose concentrations throughout the duration of the experiments. The slope of OCT signals changed significantly (up to 2.8% per 10 mg/dl) with variation of plasma glucose values. The good correlation obtained between the OCT signal slope and blood glucose concentration is due to the coherent detection of backscattered photons, which allows measurements of OCT signal from a specific tissue layer without unwanted signal from other tissue layers. CONCLUSIONS: This pilot study demonstrated the capability of the OCT technique to monitor blood glucose concentration noninvasively in human subjects. Further studies with a larger number of subjects including diabetic subjects are planned to validate these preliminary results.
Authors: Erik Johannessen; Olga Krushinitskaya; Andrey Sokolov; Häfliger Philipp; Arno Hoogerwerf; Christian Hinderling; Kari Kautio; Jaakko Lenkkeri; Esko Strömmer; Vasily Kondratyev; Tor Inge Tønnessen; Tom Eirik Mollnes; Henrik Jakobsen; Even Zimmer; Bengt Akselsen Journal: J Diabetes Sci Technol Date: 2010-07-01
Authors: Mattia Zanon; Giovanni Sparacino; Andrea Facchinetti; Michela Riz; Mark S Talary; Roland E Suri; Andreas Caduff; Claudio Cobelli Journal: Med Biol Eng Comput Date: 2012-06-22 Impact factor: 2.602
Authors: Andreas Caduff; Mattia Zanon; Martin Mueller; Pavel Zakharov; Yuri Feldman; Oscar De Feo; Marc Donath; Werner A Stahel; Mark S Talary Journal: J Diabetes Sci Technol Date: 2015-04-24
Authors: Mohamad G Ghosn; Michael Leba; Astha Vijayananda; Panteha Rezaee; Joel D Morrisett; Kirill V Larin Journal: J Biophotonics Date: 2009-10 Impact factor: 3.207